1. Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
- Author
-
Mamoru Shibata, Naoki Miyazaki, Jin Nakahara, Narumi Watanabe, Naoki Hasegawa, Shunsuke Uno, Koji Sekiguchi, Tsubasa Takizawa, Kei Ishizuchi, Yu Tagashira, Ryo Takemura, and Chisato Iba
- Subjects
Pediatrics ,medicine.medical_specialty ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Cross-sectional study ,business.industry ,Incidence (epidemiology) ,Incidence ,Vaccination ,Headache ,COVID-19 ,General Medicine ,medicine.disease ,medicine.disease_cause ,Cross-Sectional Studies ,Migraine ,medicine ,Humans ,Neurology (clinical) ,Headaches ,medicine.symptom ,business ,Adverse effect ,Coronavirus - Abstract
Background Headache is an adverse event of coronavirus 2019 (COVID-19) vaccination. Whether patients with history of headache suffer more from vaccination-induced headaches is unknown. We aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls. Methods We performed a questionnaire survey for nursing staff in our hospital from April to May 2021. Based on baseline characteristics, we divided the participants into migraine, non-migrainous headache, and healthy control, and examined the occurrence and features of headache after COVID-19 vaccinations. Results We included 171 participants (15.2% migraine and 24.6% non-migrainous headache). Headache incidence after vaccinations was significantly higher in the migraine (69.2%) and non-migrainous headache (71.4%) groups than in the healthy control (37.9%) group. The incidence of headaches was significantly higher after the second dose compared to the first (45.6% vs. 20.5%). Conclusion Migraineurs and non-migrainous headache participants developed more headaches compared to the healthy controls after COVID-19 vaccination.
- Published
- 2021